scispace - formally typeset
W

Walid Saliba

Researcher at Cleveland Clinic

Publications -  430
Citations -  21917

Walid Saliba is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Atrial fibrillation & Catheter ablation. The author has an hindex of 70, co-authored 359 publications receiving 19254 citations. Previous affiliations of Walid Saliba include Tel Aviv University & Rappaport Faculty of Medicine.

Papers
More filters
Journal ArticleDOI

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Bruce L. Wilkoff, +98 more
- 25 Dec 2002 - 
TL;DR: For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual-chamber pacing offers no clinical advantage over ventricular backup pacing and may be detrimental by increasing the combined end point of death or hospitalization for heart failure.
Journal ArticleDOI

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial

TL;DR: PVI with radiofrequency ablation appears to be a feasible first-line approach for treating patients with symptomatic AF, and improvement in quality of life of patients in the PVI group was significantly better than the improvement in the antiarrhythmic drug group in 5 subclasses of the Short-Form 36 health survey.

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation

TL;DR: A multicenter prospective randomized study conducted from December 31, 2001, to July 1, 2002, of 70 patients aged 18 to 75 years who experienced monthly symptomatic atrial fibrillation episodes for at least 3 months and had not been treated with antiarrhythmic drugs was conducted in this article.